Long-term outcomes in patients with platinum-sensitive recurrent ovarian cancer receiving ≥ 2 year duration of maintenance PARP inhibitor therapy

International Journal of Gynecological Cancer 2026

View at publisher
Authors: Apini Patel, Rowan E. Miller, Jonathan Andrew Ledermann, Michael J. Flynn, Shibani Nicum, Michelle Lockley, Shanthini Mary Crusz, Alison Berner, Michael-John Devlin
DOI: 10.1016/j.ijgc.2025.103867
Cited by: 0

Fields of Study & Subjects

PARP inhibition in cancer therapy Ovarian cancer diagnosis and treatment BRCA gene mutations in cancer

Publication details

Journal / source
International Journal of Gynecological Cancer
Volume
36
Issue
2
Pages
103867–103867
Publication date
1 February 2026
Language
EN